In December, we asked Medical Design Briefs’ readers to cast their ballot to choose from our eight Products of the Month the technology they felt was the most significant new introduction to the design engineering community in 2025. This year, our winner reflects the industry’s need to lower costs and minimize material usage. Here is the winner of the 2025 Medical Design Briefs’ Readers’ Choice Products of the Year.
Ready-to-Use Primary Containers
Plastic Ingenuity , Cross Plains, WI, has introduced validated thermoformed ready-to-use pharma tubs. The tubs are comparable to traditional injection molded tubs; however, they offer rapid development, a lower cost of entry, and material reductions. They are commonly made from high impact polystyrene (HIPS) or polyethylene terephthalate glycol (PETG). A proprietary clean trim technology mitigates particulate. Designed to meet ISO 11040, the RTU containers accommodate syringes, vials, and cartridges.
Plastic Ingenuity’s ready-to-use (RTU) primary containers represent a meaningful advancement in pharmaceutical packaging, addressing long-standing industry challenges around speed, cost, and contamination control. These validated thermoformed tubs demonstrate how alternative manufacturing approaches can meet stringent pharmaceutical requirements while improving efficiency across the supply chain.
Faster tooling and development cycles enable pharmaceutical manufacturers to respond more quickly to market demand, clinical trial timelines, and evolving drug-delivery formats — an increasingly critical advantage as biologics and personalized therapies proliferate.
Material efficiency is another key differentiator. By leveraging thermoforming with materials such as HIPS and PETG, the tubs achieve material reductions compared to conventional molded alternatives. This not only reduces cost but also supports broader industry goals around sustainability and responsible material use, without compromising structural integrity or compatibility with aseptic processing.
Sherrie Trigg
Editor and Director of Medical Content
